F
Fate Therapeutics, Inc. (FATE)
NGM – Real Time Price. Currency in USD
2.25
+0.07 (3.21%)
At close: May 12, 2026, 4:00 PM EDT
2.18
-0.07 (-3.11%)
After-hours: May 12, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
2.25
+0.07 (3.21%)
At close: May 12, 2026, 4:00 PM EDT
2.18
-0.07 (-3.11%)
After-hours: May 12, 2026, 7:53 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.79 | 6.05 | 10 | |
| Quick ratio | 5.79 | 5.63 | 10 | |
| Debt to Equity | 0.38 | 0.30 | 7.0 | |
| Debt to Assets | 0.24 | 1.04 | 7.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 96M | 64M | 14M | 7M | 7M |
| Gross Profit | 83M | 45M | -5M | -6M | -6M |
| Operating Income | -308M | -178M | -196M | -147M | -148M |
| Net Income | -282M | -161M | -186M | -136M | -136M |
| EBITDA | -295M | -159M | -177M | -134M | -135M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -8.42 | 12.5 | 4.0 |
| Next quarter | -21.77 | 1.57 | 2.0 |
| Current year | -10.21 | 1.42 | 2.0 |
| Next year | -2.94 | 5.79 | 3.0 |
| Weighted average score | 2.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -21.36 | -0.37 | 0 | 7.79 | 2.3 |
| Y/Y | -26.39 | 37.92 | 38.64 | 12.16 | 7.0 |
| 3y average | -54.59 | 17.99 | 24.51 | 23.76 | 7.5 |
| 5y average | -2.73 | -0.22 | 7.39 | -69.03 | 2.0 |
| Weighted average score | 4.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $77.8M significantly exceeds cash reserves ($46.6M), raising financial stability concerns
Total current assets $208.7M exceed Total current liabilities $36.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$24.5M limits the company's ability to reinvest or pay down debt